title: [Panitumumab-induced trichomegaly].
authors.affiliation: Departamento de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, España. sergiovano@yahoo.es
authors.forename: Sergio
authors.initials: S
authors.lastname: Vañó-Galván
authors.forename: Federico
authors.initials: F
authors.lastname: Longo
authors.forename: Emiliano
authors.initials: E
authors.lastname: Grillo
authors.forename: Pedro
authors.initials: P
authors.lastname: Jaén
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000601:surgery; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000502:physiology; D005140:Eyelashes / Q000187:drug effects* / Q000254:growth & development; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006201:Hair Diseases / Q000139:chemically induced*; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D000077544:Panitumumab
chemical_list: D000911:Antibodies, Monoclonal; D009363:Neoplasm Proteins; D000077544:Panitumumab; C512478:EGFR protein, human; D066246:ErbB Receptors; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin